Cleared Traditional

K031800 - SOLARC/SOLRX 500 SERIES ULTRAVIOLET PHOTOTHERAPY LAMP UNIT FAMILY A NEW MEDICAL DEVICE FAMILY CONSISTING OF 5 MODELS:

K031800 is an FDA 510(k) clearance for SOLARC/SOLRX 500 SERIES ULTRAVIOLET PHO..., manufactured by Solarc Systems, Inc.. The device is a Class 2 General & Plastic Surgery device with product code FTC cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K031800 · Solarc Systems, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2003
Decision
91d
Days
Class 2
Risk

K031800 is an FDA 510(k) clearance for the SOLARC/SOLRX 500 SERIES ULTRAVIOLET PHOTOTHERAPY LAMP UNIT FAMILY A NEW MEDIC.... Classified as Light, Ultraviolet, Dermatological (product code FTC), Class II - Special Controls.

Submitted by Solarc Systems, Inc. (Barrie, Ontario, CA). The FDA issued a Cleared decision on September 10, 2003 after a review of 91 days - within the typical 510(k) review window.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4630 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Solarc Systems, Inc. devices

FDA 510(k) Submission Details - K031800

510(k) Number K031800 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 11, 2003
Decision Date September 10, 2003
Days to Decision 91 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 115d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FTC Device Classification - Class 2, Special Controls

Product Code FTC Light, Ultraviolet, Dermatological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - FTC Light, Ultraviolet, Dermatological

All 52
Devices cleared under the same product code (FTC) and FDA review panel - the closest regulatory comparables to K031800.
PANOSOL II TRU-BLU, MODEL UBL-417
K070934 · National Biological Corp. · May 2007
CYNOSUREA ECLILITE AND ECLILITE U
K050080 · Cynosure, Inc. · May 2005
HOUVA 3 PHOTOTHERAPY SYSTEM
K041212 · National Biological Corp. · Jun 2004
BCLEAR
K021762 · Lumenis, Inc. · Aug 2002
HANDISOL WOUND HEALING
K982082 · National Biological Corp. · Oct 1998
UVISOL AND UVISOL II
K934808 · National Biological Corp. · Dec 1993